CAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), a leading live biotherapeutics company, today announced that Eric Shaff, President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024, at 4:30 p.m. ET.A live webcast of the chat will be accessible through the "Events and Presentations" tab on the "Investors and News" section of the Company's website at www.serestherapeutics.com and will be available for replay following ...Full story available on Benzinga.com
Seres Therapeutics is a Massachusetts-based biotechnology company that researches and develops novel microbiome therapeutics for the treatment of gastrointestinal infections.